# Elyse S. Rafal, M.D. – FDA Inspection, Nov 24, 2025

Source: https://www.keypedia.com/records/fda_inspections/elyse-s-rafal-md/699fa502-bb8f-452f-9c73-24927d307fa3
Source feed: FDA_Inspections

> FDA inspection 1292742 of Elyse S. Rafal, M.D., November 24, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1292742
- Company Name: Elyse S. Rafal, M.D.
- Inspection Date: 2025-11-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New York District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1247249 - 2024-08-01
- FDA Inspection 1192289 - 2022-11-17

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/roberto-a-dookhan/01c2225f-a885-4421-9967-da323ce55cd8)

Company: https://www.keypedia.com/companies/elyse-s-rafal-md/aa8514f3-88d5-4eaf-a609-5b928a2a542c

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d
